Lowest Price Guaranteed
Pages
212
Last Updated
September 2026
View Count
29258
The global digital pathology market, valued at USD 1.01 billion in 2025, is projected to reach USD 1.09 billion in 2026 and USD 2.32 billion by 2035, with a 8.74% CAGR during the forecast period 2026 to 2035.
 |
To learn more about this report, request a free sample copy
Pathology is a field of medical science that aids in the detection or recognition of diseases. Besides diagnosing diseases, pathology assists in examining nature, fluid, and cause of illness. In digital pathology, glass slides are converted into digital format, connected to a virtual microscope and pathologists analyze the organ cells, interpret digital images of tissue samples through AI advanced HD imaging software and tools.
 |
 |
 |
According to the National Cancer Institute , in 2024, around 2.0 million new cases of cancer were estimated to be diagnosed in the US, 15.5% of new breast cancer cases and 14.9% of prostate cancer were predicted to register. While lung cancer was the most common cancer-causing death with 26.7% of cases. This spike in the growing incidence of cancer, due to the rise in geriatric population around the world, will augment the demand for digital pathology services to overcome the workload of diagnosis tests.
 |
 |
 |
In addition, the rising proliferation of advanced technology has boosted the adoption of AI based digital pathology services to improve the capacity of diagnostic, enhanced image analysis, and efficient workflows.
 |
 |
 |
| Key Report Attributes | Details | |
| Historical Trend | Since 2018 | |
| Forecast Period | Till 2035 | |
| Market Size 2026 | $ 1.09 Billion | |
| Market Size 2035 | $ 2.32 Billion | |
| CAGR | 8.74% | |
The digital pathology market analysis also features the likely distribution of the current and forecasted opportunity within the digital pathology domain across various segments, such as type of neural network, type of assay, type of end-user, area of application, target disease indication and geographical regions.
We have created three market forecast scenarios, conservative, base and optimistic, to account for future uncertainties in key parameters and enhance the robustness of our model. These scenarios represent different tracks of the industry's evolution.
Apart from accurate diagnostic competence, the advantages of digital pathology in improving the collaboration among different pathologists, ensuring long-term preservation of specimens and integrating artificial intelligence for automated analysis support the market demand.
Several recent developments have taken place in the field of digital pathology, and we outline some of these below. These developments, even if they arose after our market report’s release, support the overall digital pathology trends detailed in our analysis.
The market research report presents an in-depth analysis of the various digital pathology companies, across different segments, as defined in the table below:
| Market Segmentations | Details | |
| Type of Neural Network |
|
|
| Type of Assay |
|
|
| End-User |
|
|
| Area of Application |
|
|
| Target Disease Indication |
|
|
| Geographical Regions |
|
|
As the global market for digital pathology increases, the demand for pathology services and solutions will increase as well. Additionally, the spike in the growing incidence of cancer, due to the rise in geriatric population around the world, will augment the demand for digital pathology service to overcome the workload of diagnosis tests.
Digital pathology domain will mark a turning point in the near future. Anil Parwani, (Chair, Department of Pathology and Chief, Laboratory Services for the Health System), states, “Digital pathology has advanced so significantly that the pathologists without digitized slides can face challenges throughout the complete pathology workflow”.
| Report Deliverables | Details | |
| Excel Data Packs (Complimentary) |
|
|
| Key Digital Pathology Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
The “Digital Pathology Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, company competitiveness analysis, funding and investments, demand analysis and market size and future opportunities within the digital pathology industry, during the forecast period.
The current market landscape of digital pathology companies, including very large, large, mid-sized and small companies. These providers have the required expertise to provide services and solutions for digital pathology, across different geographical regions.
The key players are adopting competitive strategies to stay ahead of the competition with their diverse range of services and solutions in digital pathology. Their emphasis on research and development to enhance the efficiency of their services and tools by entering into strategic partnership and collaboration with other research institutions, healthcare settings and technological service providers aid them to expand their market reach.
The global digital pathology industry size is likely to be worth $ 1.09 billion in 2026 and will reach $ 2.32 billion by 2035. In terms of the type of neural network, convolutional networks segment holds the largest share of the digital pathology market due to their potential to identify subtle morphological patterns. The market size for neural networks is likely to grow at a relatively higher CAGR during the forecast period.
The growing adoption of telepathology adoption in clinical laboratories and remote diagnostics and the growing investments in healthcare infrastructure and R&D are the primary drivers of this market. Further, the rising prevalence of chronic disorders and cancer is likely to significantly drive the growth of this market.
North American companies will likely dominate the global digital pathology industry. The majority of digital pathology companies are headquartered in North America, Europe followed by Asia-Pacific. It is important to highlight that the market in North America is fueled by a strong healthcare infrastructure, supportive regulations and the increasing need for efficient and accurate diagnostic solutions for a growing burden of chronic diseases.
The market in Asia-Pacific is expected to grow at a relatively high CAGR, during the forecast period till 2035. This is due to several factors, including growing awareness and acceptance of digital therapeutics solutions and rising adoption of telepathology and remote diagnostics.
The increasing global burden of chronic diseases has driven the need for efficient digital pathology solutions, which, in turn, fuels the growth of digital pathology services. Additionally, the integration of digital pathology with precision medicines has amplified the integration of digital pathology into healthcare practices.
At the same time, the use of digital pathology for early cancer diagnostics is also gaining the interest of several large drug developers. The first digital pathology companion diagnostic received Breakthrough Device Designation from the FDA in April 2025. The test VENTANA TROP2 (EPR20043) RxDx from Roche Diagnostics uses artificial intelligence-based image analysis. The test is being developed for identifying patients with non-small cell lung cancer who are most likely to benefit from treatment with Daiichi Sankyo and AstraZeneca’s DATROWAY®, an antibody drug conjugate. In March 2025, AstraZeneca also partnered with Mindpeak to assess the potential of latter’s Breast H&E AI powered to analyze H&E-stained images of breast cancer patient samples.
Digital pathology providers have forged several partnerships with other stakeholders to enhance their solution portfolios. Notably, in the last five years, companies based in North America and Europe have inked several partnerships to strengthen their digital pathology capabilities. For instance, In April 2025, Mindpeak and DigitCells signed an agreement to integrate Mindpeak’s AI algorithms into DigitCells’ digital pathology platform, aiming to significantly enhance diagnostic accuracy, efficiency, and workflow optimization for pathology labs across the US.
Even hospitals / healthcare facilities are partnering with digital pathology platform providers to improve the personalized care offered to patients. In March 2025, France based Paris Saint-Joseph Hospital and Marie Lannelongue Hospital entered into collaboration with Philips to integrate digital pathology into their imaging workflows.
Digital pathology providers have undertaken several initiatives in order to support the growing demand for digital pathology solutions. In January 2024, Deciphex raised close to $32.2 million to accelerate pathology AI foundational mode development with the aim to meet the growing demand for digital pathology solutions.
Such recent developments in this segment indicate that the providers are upgrading their capabilities and infrastructure to accommodate the current and anticipated digital pathology solutions demand. In the past few years, around USD 2 billion has been invested across 60 funding instances. As surge in funding allows key companies to invest in research and development projects for developing cutting-edge-technology which reinforces them in expanding their product portfolio.
The rising proliferation of advanced technology is one of the latest trends in the healthcare industry, influencing the digital pathology market. The continuous advancement in technology such as artificial intelligence and machine learning is enhancing the capability of digital technology.
To leverage technological advancements, service vendors are increasingly adopting these tools which assist pathologists in smoothing existing digital pathology workflow, streamlining the diagnostic process and improving productivity. Besides this, the trend of raising funds and investments in the market is generating remunerative opportunities for market players.
The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders in the digital pathology industry, across different geographical regions. Amongst other elements, the market report includes:
Some of the potential market drivers that are propelling growth in this domain include the need for increased efficiency and speed in diagnosis and the advancements in technology. It is worth highlighting that the governments are recognizing the potential of digital pathology and are providing funding support for the adoption of these solutions. Therefore, with the ongoing technological advancements in this domain, we anticipate a steady digital pathology market growth, till 2035.